Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Amylyx Pharmaceuticals, Inc. | Chief Medical Officer | Common Stock | 206K | $3.36M | $16.33 | Jan 9, 2024 | Direct |
Amylyx Pharmaceuticals, Inc. | Chief Medical Officer | Stock Option (right to buy) | 33.8K | May 15, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AMLX | Amylyx Pharmaceuticals, Inc. | Jan 9, 2024 | 1 | -$45.9K | 4 | Jan 11, 2024 | Chief Medical Officer |
AMLX | Amylyx Pharmaceuticals, Inc. | May 15, 2023 | 5 | -$279K | 4 | May 17, 2023 | Chief Medical Officer |
AMLX | Amylyx Pharmaceuticals, Inc. | Apr 17, 2023 | 6 | -$1.46M | 4 | Apr 19, 2023 | Chief Medical Officer |
AMLX | Amylyx Pharmaceuticals, Inc. | Mar 16, 2023 | 10 | -$1.61M | 4/A | Mar 24, 2023 | Chief Medical Officer |
AMLX | Amylyx Pharmaceuticals, Inc. | Jan 6, 2023 | 2 | $73.8K | 4 | Jan 10, 2023 | Chief Medical Officer |
AMLX | Amylyx Pharmaceuticals, Inc. | Jan 6, 2022 | 2 | $0 | 4 | Jan 10, 2022 | Chief Medical Officer |
AMLX | Amylyx Pharmaceuticals, Inc. | Jan 6, 2022 | 0 | $0 | 3 | Jan 6, 2022 | Chief Medical Officer |